» Articles » PMID: 36950036

Preferences for Pre-exposure Prophylaxis (PrEP) Among Sexual and Gender Minorities: a Discrete Choice Experiment in Brazil

Abstract

Background: Men who have sex with men (MSM) and transgender women (TGW) are disproportionally affected by HIV infection in Latin America. This study aims to assess pre-exposure prophylaxis (PrEP) preferences among sexual and gender minorities (SGM) and identify attributes and levels that are related to PrEP uptake and adherence, both crucial for PrEP success.

Methods: We conducted a discrete choice experiment (DCE) among SGM from all Brazilian regions (September-December/2020). The survey was administered face-to-face (five Brazilian capitals) and online (entire country). We used a D-efficient zero-prior blocked experimental design to select 60 paired-profile DCE choice tasks.

Findings: The total sample size was 3924 (90.5% MSM; 7.2% TGW and 2.3% non-binary or gender diverse persons). In random-effects logit models, highest levels of protection and "no side effects" were the most important attribute levels. For "presentation", injectable and implant were preferred over oral. Participants were willing to accept a 4.1% protection reduction to receive injectable PrEP or a 4.2% reduction if PrEP were taken monthly. The largest class in the latent class models was defined predominantly by the preference for the highest HIV protection level (p < 0.005). Respondents in this class also preferred no side effects, injectable and implant presentations.

Interpretation: Higher HIV protection, no side effects, and presentation, whether injectable or implant, were the most important attributes in PrEP preferences. Protection against HIV was the most important attribute. PrEP programs should make available technologies such as long-acting presentations that could reunite the most desired attributes, thus maximizing acceptability and user-appropriateness.

Funding: Unitaid.

Citing Articles

Preferences for HIV pre-exposure prophylaxis formulations and delivery among young African women: results of a discrete choice experiment.

Dlamini W, Mirembe B, Krows M, Peacock S, Kotze P, Selepe P J Int AIDS Soc. 2025; 28(2):e26422.

PMID: 39956930 PMC: 11830565. DOI: 10.1002/jia2.26422.


Sociodemographic and clinical follow-up profile of transgender people accessing pre-exposure prophylaxis for the risk of HIV transmission in São Paulo, Brazil (2018-2021).

Silva M, Estevam D, Cardoso M, Nichiata L Epidemiol Serv Saude. 2024; 33(spe1):e2024342.

PMID: 39699388 PMC: 11654812. DOI: 10.1590/S2237-96222024v33e2024342.especial.en.


Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study.

Pimenta M, Torres T, Hoagland B, Cohen M, Mann C, Jalil C JMIR Public Health Surveill. 2024; 10:e60961.

PMID: 39446416 PMC: 11544328. DOI: 10.2196/60961.


Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study.

Torres T, Teixeira S, Hoagland B, Konda K, Derrico M, Moreira R Lancet Reg Health Am. 2023; 28:100642.

PMID: 38076411 PMC: 10704427. DOI: 10.1016/j.lana.2023.100642.


Analysis of online user discussions on Reddit associated with the transition of use between HIV PrEP therapy.

Godinez H, Xu Q, McMann T, Li J, Mackey T Front Public Health. 2023; 11:1073813.

PMID: 37457283 PMC: 10338828. DOI: 10.3389/fpubh.2023.1073813.


References
1.
Clark M, Determann D, Petrou S, Moro D, de Bekker-Grob E . Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014; 32(9):883-902. DOI: 10.1007/s40273-014-0170-x. View

2.
Fontanari A, Zanella G, Feijo M, Churchill S, Lobato M, Costa A . HIV-related care for transgender people: A systematic review of studies from around the world. Soc Sci Med. 2019; 230:280-294. DOI: 10.1016/j.socscimed.2019.03.016. View

3.
Bridges J, Hauber A, Marshall D, Lloyd A, Prosser L, Regier D . Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011; 14(4):403-13. DOI: 10.1016/j.jval.2010.11.013. View

4.
Chakrapani V, Newman P, Cameron M, Shunmugam M, Roungprakhon S, Rawat S . Willingness to Use Pre-exposure Prophylaxis (PrEP) and Preferences Among Men Who have Sex with Men in Mumbai and Chennai, India: A Discrete Choice Experiment. AIDS Behav. 2021; 25(10):3074-3084. DOI: 10.1007/s10461-021-03253-5. View

5.
Grinsztejn B, Hoagland B, Moreira R, Kallas E, Madruga J, Goulart S . Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. Lancet HIV. 2018; 5(3):e136-e145. DOI: 10.1016/S2352-3018(18)30008-0. View